Hospitals

MAUI Imaging Emerges From Stealth With $4 Million Department of Defense Contract To Support Trauma Medicine

Novel FDA-cleared imaging technology reveals anatomy that traditional ultrasound devices cannot; initial focus on trauma as well as neurosurgery and…

5 months ago

Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ethyl) REDUCE-IT® Subgroup Data and New Mechanistic Insights into Eicosapentaenoic Acid (EPA) to be Presented at European Society of Cardiology (ESC) Congress

DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced new supported and/or…

5 months ago

TOMI Environmental Solutions Expands Partnership With A Global Leader in Laboratory Services

$715,000 Order Includes SteraMist Mobile Equipment and A Custom Engineered SystemFREDERICK, Md., Aug. 22, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental…

5 months ago

Ultrasound Market to be Worth $18.07 billion by 2031 – Exclusive Report by Meticulous Research®

REDDING, Calif., Aug. 21, 2024 /PRNewswire/ -- According to a new market research report, 'Ultrasound Market Size, Share, Forecast, & Trends Analysis…

5 months ago

Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States

BOULDER, CO / ACCESSWIRE / August 21, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing…

5 months ago

PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy

Designed to improve efficiency, enhance surgeon and staff experience and deliver a more accurate and consistent treatment plan for better…

5 months ago

Contessa Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model

Guiding an Improved Dementia Experience (GUIDE) Model Aims to Increase Care Coordination, Support for CaregiversNASHVILLE, Tenn., Aug. 21, 2024 (GLOBE…

5 months ago

Ultimovacs ASA Reports Second Quarter 2024 Financial Results and Provides General Business Update

Oslo, August 21, 2024: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical-stage biotechnology company developing novel immunotherapies against cancer, announces its…

5 months ago

Encision Signs Master Services Agreement with Vicarious Surgical Inc.

BOULDER, CO / ACCESSWIRE / August 21, 2024 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active…

5 months ago